Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease.
about
Topical Review: Basal Ganglia: Functional Anatomy and Physiology. Part 1Huntingtin-associated protein (HAP1): discrete neuronal localizations in the brain resemble those of neuronal nitric oxide synthaseNeuropeptide Y: A stressful review.Genetics and neuropathology of Huntington's diseaseNeuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragment.Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1.Neurotransmitter distribution in the second trimester fetal human corpus striatum.CalDAG-GEFI down-regulation in the striatum as a neuroprotective change in Huntington's disease.Striatal Vulnerability in Huntington's Disease: Neuroprotection Versus Neurotoxicity.Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic miceDistribution of GABAergic interneurons and dopaminergic cells in the functional territories of the human striatum.Animal models of Huntington's disease.Aminooxyacetic acid results in excitotoxin lesions by a novel indirect mechanism.Neurotrophins and neurodegeneration.New insights into the clinical features, pathogenesis and molecular genetics of Huntington disease.Huntington's Disease and Striatal Signaling.Human brain somatostatin release from isolated cortical nerve endings and its modulation through GABAB receptors.Differential localization of the GluR1 and GluR2 subunits of the AMPA-type glutamate receptor among striatal neuron types in rats.The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration.Striatal microcircuitry and movement disordersAnimal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies.Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington's disease and mouse models.Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: clinical consequences and therapeutic implications.Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine.The clinical and genetic features of Huntington disease.Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses.The Complexity of Clinical Huntington's Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers.Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R.The calretinin interneurons of the striatum: comparisons between rodents and primates under normal and pathological conditions.Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin.Toward understanding the molecular pathology of Huntington's disease.Quinolinic acid stimulates somatostatin gene expression in cultured rat cortical neurons.Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues.The HIV-1 coat protein gp120 and some of its fragments potently activate native cerebral NMDA receptors mediating neuropeptide release.Preferential interneuron survival in the transition zone of 3-NP-induced striatal injury in rats.Distribution of altered hippocampal neurons and axons immunoreactive with antisera against neuropeptide Y in Alzheimer's-type dementia.Distribution of neurons and axons immunoreactive with antisera against neuropeptide Y in the normal human hippocampus.Evidence for functional native NMDA receptors activated by glycine or D-serine alone in the absence of glutamatergic coagonist.Somatostatin release from rat cerebral cortex synaptosomes.Disrupted striatal neuron inputs and outputs in Huntington's disease.
P2860
Q22337010-1564A559-14DA-4E62-924E-0CEAC0BD695DQ24601142-15D18803-2C8A-4FAF-8A5A-7BA77AE4FFE0Q26781704-AEAEDC49-CD3A-4CF5-AC0E-690FCFAD6A93Q27023050-FBE71F37-1BD8-4F77-8CFE-D4149479F3DDQ30315395-D79C665C-9114-49A5-9D57-CEF59CEA09F2Q31129663-C6893E78-2744-4057-A677-128D5465769AQ32039169-F530FA56-AB5B-4167-80E1-B505DCDFE20BQ33773689-F0517031-256F-48A4-B74B-C2C45A331175Q33831774-C2C6B67B-BE34-43CA-A35B-D416975D7708Q34017941-63B91ABF-D4F6-48D4-BE5B-A6F9BE7786A5Q34137813-3237A98B-8F2A-4213-B138-F2EDE411FA78Q34665829-8C72E2D4-5020-48E0-B788-E393FF8680C8Q34756401-5C6FC094-E54F-4ABD-8E48-02E90F406C4EQ35145450-2C086680-D69A-4228-8C79-09FDD1DD8F52Q35243890-0EA2BDF5-C0B0-42A6-B5AD-267660ACBB68Q35286098-4D8F42F4-45F0-452B-A308-CD3159A139E3Q35873781-89786443-B7D1-4B90-BE6D-E51D7332009CQ36012795-4C584ACA-869E-4FEA-9D2E-846636AB4724Q36045254-7EAADC80-7CBB-42B7-AA39-FE51610A9B6DQ36203205-A9089F40-EF50-4484-8307-2BFEE3561DB7Q36606399-F8676732-D1A8-4EAD-9D2B-5E8285F31848Q36975938-6E5D7C10-D3D3-404A-90C5-675877C1F791Q37003956-7E4F64BF-8C15-4985-9E5E-4730D5612FCCQ37242921-9015ABB8-3271-4E9D-ABCF-E5E0A7B44BFFQ37798079-BFB752EA-3266-453C-9ACA-0632B1390ED9Q37898251-7F4CD34B-B694-44AC-A9E0-CD06E1820836Q38663086-CF7BC5A9-178A-405D-BA05-FAC6E76EEC1EQ39079841-5CE80C6B-2702-42B8-8CC3-3FD7295D9865Q39123728-164DE2C1-B613-45DC-9155-D5EBE46D2568Q40958511-F82F9DF6-F49F-4D52-AE2A-FCDFAFB79773Q41527106-6E1D510E-0EC0-46A3-9053-5AF4CC3CA14BQ42052839-1CC992F6-8369-4A82-A14D-C190009575E3Q42503942-6E966D3A-7128-4B6F-B3DA-11F3193F548AQ43693405-8A5D9F3A-D909-4F49-9B11-84B993BD0403Q45301807-13C3B29E-188F-430D-94FA-45D4045AE9C4Q48333051-37F3C3E0-F6A0-4268-85F1-C42AE095FFAEQ48333061-89DC6523-1C0E-4D17-8E01-460B4BB4F233Q48383183-458BAEA1-895E-4613-B4FB-D585ECE20D53Q48651265-0EF5684A-189F-460C-A93E-1E19FF0D11F9Q52690256-A821EE87-7D78-449B-8CF3-AB057F635C2B
P2860
Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease.
@en
Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease.
@nl
type
label
Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease.
@en
Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease.
@nl
prefLabel
Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease.
@en
Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease.
@nl
P2093
P1433
P1476
Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease.
@en
P2093
P304
P356
10.1016/0006-8993(85)90921-7
P407
P577
1985-08-01T00:00:00Z